
    
      This study is a post market clinical follow up study performed to confirm the performance of
      BrOxy M pulse oximeter in comparison with a reference, CE marked, pulse oximeter equipment
      (Nellcorâ„¢ Bedside Respiratory Patient Monitoring System model PM1000N, Covidien LLC, USA) in
      a controlled desaturation study over a range between 80% and 100% SpO2.

      The study will be performed on a group of healthy volunteers in a controlled clinical
      setting. Due to the use of a controlled desaturation protocol foreseen by the standard ISO
      80601-2-61:2017, this study is classified as an interventional post-market clinical study in
      accordance with Annex I of EN ISO 14155:2020.
    
  